Browsing bySubjectImmune checkpoint inhibitor

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 3 of 3

Issue DateTitleAuthor(s)Type
2021Analysis of risk factors for hepatotoxicity induced by immune checkpoint inhibitors곽혜선Article
2020Real-world experience of pembrolizumab monotherapy in patients with recurrent or persistent cervical cancer: A korean multi-center retrospective study (KGOG1041)김미경Article
2022The value measurement of emerging therapeutics in renal cell carcinoma: ASCO value framework and ESMO-MCBS배승진Article

BROWSE